Ethnic differences in acute promyelocytic leukaemia between New Zealand Polynesian and European patients

References

• Rowley JD, Golomb HM, Dougherty C. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet. 1977;1:549–550. doi:https://doi.org/10.1016/s0140-6736(77)91415-5.
   PubMed Web of Science ®Google Scholar
• Liquori A, Ibanez M, Sargas C, et al. Acute promyelocytic leukemia: a constellation of molecular events around a single PML-RARA fusion gene. Cancers (Basel). 2020;12;624. doi:https://doi.org/10.3390/cancers12030624.
   Web of Science ®Google Scholar
• Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937–951. doi:https://doi.org/10.1182/blood-2009-03-209262.
   PubMed Web of Science ®Google Scholar
• David S, Mathews V. Mechanisms and management of coagulopathy in acute promyelocytic leukemia. Thromb Res. 2018;164(Suppl 1):S82–S88. doi:https://doi.org/10.1016/j.thromres.2018.01.041.
   PubMedGoogle Scholar
• Lo-Coco F, Avvisati G, Vignetti M, et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med. 2013;369:111–121. doi:https://doi.org/10.1056/NEJMoa1300874.
   PubMed Web of Science ®Google Scholar
• Douer D, Preston-Martin S, Chang E, et al. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood. 1996;87:308–313. https://www.ncbi.nlm.nih.gov/pubmed/8547657.
   PubMed Web of Science ®Google Scholar
• Douer D. The epidemiology of acute promyelocytic leukaemia. Best Pract Res Clin Haematol. 2003;16:357–367. doi:https://doi.org/10.1016/s1521-6926(03)00065-3.
   PubMed Web of Science ®Google Scholar
• Rego EM, Jacomo RH. Epidemiology and treatment of acute promyelocytic leukemia in latin america. Mediterr J Hematol Infect Dis. 2011;3:e2011049, doi:https://doi.org/10.4084/MJHID.2011.049.
   PubMedGoogle Scholar
• Gómez-Almaguer D, Marcos-Ramírez ER, Montaño-Figueroa EH, et al. Acute leukemia characteristics are different around the world: the Mexican perspective. Clin Lymphoma Myeloma Leuk. 2017;17:46–51. doi:https://doi.org/10.1016/j.clml.2016.09.003.
   PubMed Web of Science ®Google Scholar
• Douer D, Santillana S, Ramezani L, et al. Acute promyelocytic leukaemia in patients originating in Latin America is associated with an increased frequency of the bcr1 subtype of the PML/RARalpha fusion gene. Br J Haematol. 2003;122:563–570. doi:https://doi.org/10.1046/j.1365-2141.2003.04480.x.
   PubMed Web of Science ®Google Scholar
• So CC, Wan TS, Chow JL, et al. A single-center cytogenetic study of 629 Chinese patients with de novo acute myeloid leukemia–evidence of major ethnic differences and a high prevalence of acute promyelocytic leukemia in Chinese patients. Cancer Genet. 2011;204:430–438. doi:https://doi.org/10.1016/j.cancergen.2011.06.003.
   PubMed Web of Science ®Google Scholar
• Xu XJ, Tang YM, Song H, et al. Long-term outcome of childhood acute myeloid leukemia in a developing country: experience from a children’s hospital in China. Leuk Lymphoma. 2010;51:2262–2269. doi:https://doi.org/10.3109/10428194.2010.518653.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhu X. Epidemiology, diagnosis and treatment of acute promyelocytic leukemia in children: the experience in China. Mediterr J Hematol Infect Dis. 2012;4:e2012012, doi:https://doi.org/10.4084/MJHID.2012.012.
   PubMedGoogle Scholar
• Testi AM, D'Angio M, Locatelli F, et al. Acute promyelocytic leukemia (APL): comparison between children and adults. Mediterr J Hematol Infect Dis. 2014;6:e2014032, doi:https://doi.org/10.4084/MJHID.2014.032.
   PubMedGoogle Scholar
• Summary of the New Zealand Population 1991-2018 Stats NZ. Available from: https://www.stats.govt.nz/topics/population.
   Google Scholar
• Soeberg M, Blakely T, Sarfati D, et al. Cancer Trends: Trends in cancer survival by ethnic and socioeconomic group, New Zealand 1991–2004. University of Otago and Ministry of Health (2012), https://www.health.govt.nz/publication/cancer-trends-trends-cancer-survival-ethnic-and-socioeconomic-group-new-zealand-1991-2004.
   Google Scholar
• Pacific People in NZ Ministry of Pacific Peoples. (2019). Available from: https://www.mpp.govt.nz/pacific-people-in-nz.
   Google Scholar
• Dachs GU, Currie MJ, McKenzie F, et al. Cancer disparities in indigenous Polynesian populations: Māori, Native Hawaiians, and Pacific people. Lancet Oncol. 2008;9:473–484.
   PubMed Web of Science ®Google Scholar
• Teng AM, Atkinson J, Disney G, et al. Ethnic inequalities in cancer incidence and mortality: census-linked cohort studies with 87 million years of person-time follow-up. BMC Cancer. 2016;16:755, doi:https://doi.org/10.1186/s12885-016-2781-4.
   PubMed Web of Science ®Google Scholar
• Dockerty JD, Cox B, Cockburn MG. Childhood leukaemias in New Zealand: time trends and ethnic differences. Br J Cancer. 1996;73:1141–1147. doi:https://doi.org/10.1038/bjc.1996.219.
   PubMed Web of Science ®Google Scholar
• Tracey MC, Carter JM. Ethnicity variables in the incidence rates of leukemias in New Zealand populations: implications for stem-cell transplantation. Am J Hematol. 2005;79:114–118. doi:https://doi.org/10.1002/ajh.20355.
   PubMed Web of Science ®Google Scholar
• Velickovic ZM, Carter JM. Feasibility of finding an unrelated bone marrow donor on international registries for New Zealand patients. Bone Marrow Transplant. 1999;23:291–294. doi:https://doi.org/10.1038/sj.bmt.1701561.
   PubMed Web of Science ®Google Scholar
• Chien N, Petrasich M, Chan G, et al. Early treatment of acute promyelocytic leukaemia is accurately guided by the PML protein localisation pattern: real-life experience from a tertiary New Zealand centre. Pathology. 2019;51:412–420. doi:https://doi.org/10.1016/j.pathol.2019.01.003.
   PubMed Web of Science ®Google Scholar
• Chien N, Varghese C, Green TN, et al. Treatment outcomes of patients with acute promyelocytic leukaemia between 2000 and 2017, a retrospective, single centre experience. Leuk Res. 2020;93:106358, doi:https://doi.org/10.1016/j.leukres.2020.106358.
   PubMed Web of Science ®Google Scholar
• Sanz MA, Lo Coco F, Martin G, et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood. 2000;96:1247–1253. https://www.ncbi.nlm.nih.gov/pubmed/10942364.
   PubMed Web of Science ®Google Scholar
• Muchtar E, Vidal L, Ram R, et al. The role of maintenance therapy in acute promyelocytic leukemia in the first complete remission. Cochrane Database Syst Rev (2013) CD009594. https://doi.org/https://doi.org/10.1002/14651858.CD009594.pub2.
   Google Scholar
• Iland HJ, Collins M, Bradstock K, et al. Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial. Lancet Haematol. 2015;2:e357–e366. doi:https://doi.org/10.1016/S2352-3026(15)00115-5.
   PubMed Web of Science ®Google Scholar
• Jacomo RH, Melo RA, Souto FR, et al. Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines. Haematologica. 2007;92:1431–1432. doi:https://doi.org/10.3324/haematol.10874.
   PubMedGoogle Scholar
• Khorshid O, Diaa A, Moaty MA, et al. Clinical features and treatment outcome of acute promyelocytic leukemia patients treated at Cairo national cancer institute in Egypt. Mediterr J Hematol Infect Dis. 2011;3:e2011060, doi:https://doi.org/10.4084/MJHID.2011.060.
   PubMedGoogle Scholar
• Lehmann S, Ravn A, Carlsson L, et al. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish adult acute leukemia Registry. Leukemia. 2011;25:1128–1134. doi:https://doi.org/10.1038/leu.2011.78.
   PubMed Web of Science ®Google Scholar
• Pagoni M, Garofalaki M, Panitsas F, et al. Acute promyelocytic leukemia: an experience on 95 Greek patients treated in the all-trans-retinoic acid era. Mediterr J Hematol Infect Dis. 2011;3:e2011053, doi:https://doi.org/10.4084/MJHID.2011.053.
   PubMedGoogle Scholar
• Russell N, Burnett A, Hills R, et al. Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial. Blood. 2018;132:1452–1454. doi:https://doi.org/10.1182/blood-2018-05-851824.
   PubMed Web of Science ®Google Scholar
• Daver N, Kantarjian H, Marcucci G, et al. Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis. Br J Haematol. 2015;168:646–653. doi:https://doi.org/10.1111/bjh.13189.
   PubMed Web of Science ®Google Scholar
• Tallman MS, Kim HT, Montesinos P, et al. Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA group. Blood. 2010;116:5650–5659. doi:https://doi.org/10.1182/blood-2010-06-288613.
   PubMed Web of Science ®Google Scholar
• Hanna MZ, Kalev-Zylinska ML, Jackson SR, et al. Distinctive features of polycythaemia vera in New Zealand Polynesians. N Z Med J. 2018;131:38–45. https://www.ncbi.nlm.nih.gov/pubmed/30235191.
   PubMed Web of Science ®Google Scholar
• Kirtane K, Lee SJ. Racial and ethnic disparities in hematologic malignancies. Blood. 2017;130:1699–1705. doi:https://doi.org/10.1182/blood-2017-04-778225.
   PubMed Web of Science ®Google Scholar
• Bispo JAB, Pinheiro PS, Kobetz EK. Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harb Perspect Med. 2020;10:a034819; doi:https://doi.org/10.1101/cshperspect.a034819.
   Google Scholar
• Landgren O. Racial/ethnic disparities: need more work!. Blood. 2017;130:1685–1686. doi:https://doi.org/10.1182/blood-2017-08-798546.
   PubMed Web of Science ®Google Scholar
• Chen C, Huang X, Wang K, et al. Early mortality in acute promyelocytic leukemia: potential predictors. Oncol Lett. 2018;15:4061–4069. doi:https://doi.org/10.3892/ol.2018.7854.
   PubMed Web of Science ®Google Scholar
• Marasca R, Maffei R, Zucchini P, et al. Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with FLT3 mutational status. Leukemia. 2006;20:103–114. doi:https://doi.org/10.1038/sj.leu.2404000.
   PubMed Web of Science ®Google Scholar
• Beitinjaneh A, Jang S, Roukoz H, et al. Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: a systematic review. Leuk Res. 2010;34:831–836. doi:https://doi.org/10.1016/j.leukres.2010.01.001.
   PubMed Web of Science ®Google Scholar
• Merriman TR, Wilcox PL. Cardio-metabolic disease genetic risk factors among Maori and Pacific Island people in Aotearoa New Zealand: current state of knowledge and future directions. Ann Hum Biol. 2018;45:202–214. doi:https://doi.org/10.1080/03014460.2018.1461929.
   PubMed Web of Science ®Google Scholar
• Minster RL, Hawley NL, Su CT, et al. A thrifty variant in CREBRF strongly influences body mass index in Samoans. Nat Genet. 2016;48:1049–1054. doi:https://doi.org/10.1038/ng.3620.
   PubMed Web of Science ®Google Scholar
• Berry SD, Walker CG, Ly K, et al. Widespread prevalence of a CREBRF variant amongst Māori and Pacific children is associated with weight and height in early childhood. Int J Obes. 2018;42:603–607. doi:https://doi.org/10.1038/ijo.2017.230.
   PubMed Web of Science ®Google Scholar
• Krishnan M, Major TJ, Topless RK, et al. Discordant association of the CREBRF rs373863828 A allele with increased BMI and protection from type 2 diabetes in Maori and Pacific (Polynesian) people living in Aotearoa/New Zealand. Diabetologia. 2018;61:1603–1613. doi:https://doi.org/10.1007/s00125-018-4623-1.
   PubMed Web of Science ®Google Scholar
• Estey E, Thall P, Kantarjian H, et al. Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia. Leukemia. 1997;11:1661–1664. doi:https://doi.org/10.1038/sj.leu.2400783.
   PubMed Web of Science ®Google Scholar
• Li S, Chen L, Jin W, et al. Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis. Sci Rep. 2017;7:17998, doi:https://doi.org/10.1038/s41598-017-18278-x.
   PubMed Web of Science ®Google Scholar
• Duncan E, Schofield G, Duncan S, et al. Ethnicity and body fatness in New Zealanders. N Z Med J. 2004;117:U913, https://www.ncbi.nlm.nih.gov/pubmed/15282625.
   PubMedGoogle Scholar
• Deng T, Lyon CJ, Bergin S, et al. Obesity, inflammation, and cancer. Annu Rev Pathol. 2016;11:421–449. doi:https://doi.org/10.1146/annurev-pathol-012615-044359.
   PubMed Web of Science ®Google Scholar
• Patel MI, Ma Y, Mitchell B, et al. How do differences in treatment impact racial and ethnic disparities in acute myeloid leukemia? Epidemiol Biomarkers Prev. 2015;24:344, doi:https://doi.org/10.1158/1055-9965.EPI-14-0963.
   PubMed Web of Science ®Google Scholar
• Fillmore NR, Yellapragada SV, Ifeorah C, et al. With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study. Blood. 2019;133:2615–2618. doi:https://doi.org/10.1182/blood.2019000406.
   PubMed Web of Science ®Google Scholar
• Rahiri JL, Alexander Z, Harwood M, et al. Systematic review of disparities in surgical care for Maori in New Zealand. ANZ J Surg. 2018;88:683–689. doi:https://doi.org/10.1111/ans.14310.
   PubMed Web of Science ®Google Scholar
• Blakely T, Ajwani S, Robson B, et al. Decades of disparity: widening ethnic mortality gaps from 1980 to 1999. N Z Med J. 2004;117:U995, https://www.ncbi.nlm.nih.gov/pubmed/15475978.
   PubMedGoogle Scholar